Under construction – not a live service
Sign in
Not yet taking people in AustriaNo phase

A smartphone app to support recovery after stroke or mini-stroke

Tests StrokeApp alongside usual care in adults after stroke or TIA.

Plain-language title generated from the registry record
Registry title: Digital Application for Stroke Health

Key facts

Where
Graz, Innsbruck, Linz, Steyr, Tulln, Vienna, and Vöcklabruck, AustriaSee the 7 sites

Where in Austria

  • Medical University of Graz, Clinical Department of General NeurologyGraz, AustriaNo longer taking part
  • Medical University of Innsbruck, Department of NeurologyInnsbruck, AustriaNo longer taking part
  • Johannes Kepler University Linz, University Hospital for NeurologyLinz, AustriaNo longer taking part
  • Pyhrn-Eisenwurzen Klinikum, Department of NeurologySteyr, AustriaNo longer taking part
  • University Hospital Tulln, Clinical Department of NeurologyTulln, AustriaNo longer taking part
  • St. John's Hospital, Vienna Department of NeurologyVienna, AustriaNo longer taking part
  • Salzkammergut Klinikum Vöcklabruck, Department of NeurologyVöcklabruck, AustriaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
VASCage GmbH
Trial code
NCT07511868
Record updated
6 April 2026
Original description
Stroke is a leading cause of death and long-term disability worldwide. Despite substantial advances in acute stroke care, there remains a lack of evidence-based digital solutions to support patients after hospital discharge. This study evaluates the effectiveness of a digital health application (StrokeApp) designed to support patients with ischemic or hemorrhagic stroke or transient ischemic attack (TIA) in secondary prevention and recovery.Read full original descriptionShow less

Evaluating a Digital Health Application for Post-stroke Care and Vascular Risk Factor Management - a Multicenter Randomized Controlled Clinical Investigation

Stroke is a leading cause of death and long-term disability worldwide. Despite substantial advances in acute stroke care, there remains a lack of evidence-based digital solutions to support patients after hospital discharge. This study evaluates the effectiveness of a digital health application (StrokeApp) designed to support patients with ischemic or hemorrhagic stroke or transient ischemic attack (TIA) in secondary prevention and recovery.

In this multicenter, randomized, controlled, open-label trial, 500 patients will be assigned in a 1:1 ratio to receive either standard care alone or standard care in combination with StrokeApp. The primary objective is to assess the impact of the application on health-related quality of life three months after discharge. Secondary and exploratory outcomes include health literacy, medication adherence, vascular risk factors, health-related behaviors, psychosocial outcomes, long-term recovery up to twelve months, as well as safety and user experience.

Inclusion: Male or female patient (biological sex) ≥18 years at the time of consent; Hospitalization for acute ischemic stroke, acute haemorrhagic stroke or TIA; Necessary Technical Equipment (smartphone or tablet computer) and skills; Able to provide informed consent.

Exclusion: Cerebral infarction due to cerebral venous thrombosis (CVT); Severe Psychiatric Conditions; Severe pre-existing cognitive impairment; Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) or other patients where salt restriction is harmful; Inability to operate the device independently (assistance from a caregiver is acceptable). E.g.:; Severe apraxia,; Severe Motor Disabilities,; Severe Visual Impairment; Severe Communication Barriers (e.g. Severe Aphasia, Severe Dysarthria); Inability to speak and read German to a level which allows fully comprehending the meaning of everything that is said and written; Women of childbearing potential not willing to adopt effective contraceptive measures during the clinical investigation; Patients who are considered to be part of the vulnerable population:; Persons unable to give consent; Minors; Persons performing military service; persons detained by court or official order or accommodated in accordance with the Accommodation Act, Federal Law Gazette No. 155/1990; Pregnant or breastfeeding women.

ClinicalTrials.gov NCT07511868